期刊文献+

醛固酮阻断剂依普利酮在心血管疾病中的作用 被引量:2

下载PDF
导出
摘要 肾素 血管紧张素 醛固酮系统过度激活及高醛固酮血症对心血管系统均有损伤作用。血管紧张素转化酶 (ACE)抑制剂和血管紧张素受体阻断剂 (ARB)已被证实可有效降低血压和保护靶器官 ,减少心力衰竭的发病率和死亡率 ;但长期使用ACE抑制剂或ARB治疗后 ,血醛固酮浓度又会回到基线水平 ,即所谓“醛固酮逃逸” ,因此降低了这些药物进一步的疗效。醛固酮受体拮抗剂螺内酯对心血管系统有显著的保护作用 ,但它的性激素相关副作用限制了其应用。新一代选择性醛固酮受体拮抗剂依普利酮为心血管疾病的治疗开辟了新的道路。
出处 《国外医学(药学分册)》 2005年第1期15-19,共5页 Foreign Medical Sciences(Section of Pharmarcy)
  • 相关文献

参考文献17

  • 1Cook CS, Berry LM, Bible RH, et al. Pharmacokinetics and metabolism of [^14C] eplerenoneafter oral administration to humans[J]. Drug Metab Dispos, 2003, 31(11):1448-1455.
  • 2White WB, Cart AA, Krause S, et al. Assessment of the novd selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension[J]. Am J Cardiol, 2003, 92(1):38-42.
  • 3Williams GH, Burgess E, Kolloch RE, et al. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension[J]. Am J Cardiol, 2004, 93(8):990-996.
  • 4Flack JM, Oparil S, Pratt JH, et al. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients [ J ]. J Am Coll Cardiol, 2003, 41 (7) :1148 - 1155.
  • 5White WB, Duprez D, St Hillaire R, et al. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension[ J]. Hypertension, 2003, 41(5):1021 - 1026.
  • 6Saruta T, Kageyama S, Ogiham T, et al. Efficacy and safety of the selective aplerenone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging study [ J ]. J Clin Hypertens (Greenwich), 2004, 6(4) : 175 - 183.
  • 7Rudolph AE, Rocha R, McMahon EG. Aldosterone target organ protection by eplerenone [ J ]. Mol Cell Endocrinol,2004, 217(1/2) :229 - 238.
  • 8Wang D, Liu YH, Yang XP, et al. Role of a selective aldosterone blocker in mice with chronic heart failure[J]. J Card Fail, 2004, 10(1):67-73.
  • 9Sehafer A, Fracearollo D, Hildemann SK, et al. Addition of the selective aldostemne receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction[J]. Cardiovasc Res, 2003, 58(3):655-662.
  • 10Schafer A, Fraccarollo D, Hildemann S, et al. Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition[J]. Thromb Haemost, 2003, 89(6) : 1024 - 1030.

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部